Clarity unveiled: Navigating cataracts and modern solutions

Written in association with: Professor Robert MacLaren
Published:
Edited by: Kate Forristal

As we age, our eyes may encounter challenges, and one common vision problem that affects millions worldwide is cataracts. Often referred to as a "clouding" of the lens, cataracts can cast a blurry veil over life's splendour.

 

 In his latest online article, Professor Robert MacLaren will delve into the intricacies of cataracts, exploring their causes, symptoms, prevention, and the modern miracles of cataract surgery that can restore the clarity of vision and improve quality of life.

 

Understanding cataracts:

Cataracts, though widely prevalent in older individuals, can occur at any age. They form when the natural proteins in the eye's lens start to clump together, obscuring light from passing through and leading to vision impairment. This gradual process results in a clouded, blurred, or dimmed vision, similar to peering through frosted glass. Cataracts can affect one or both eyes, but they do not spread from one eye to the other.

 

Causes of cataracts:

While age is the most common factor contributing to cataracts, other causes include:

 

a) Genetics: Family history of cataracts may increase the likelihood of developing them.

 

b) Diabetes: High blood sugar levels can lead to the formation of cataracts.

 

c) Lifestyle choices: Poor nutrition can accelerate cataract development.

 

d) High myopia: Cataracts develop much earlier in very short-sighted people.

 

e) Trauma: Eye injuries or retinal surgery can trigger a cataract in the affected eye.

 

Recognising the symptoms:

 Identifying cataracts early is crucial for timely intervention. Common symptoms include:

 

a) Changes in spectacle prescription: In the early stages, cataracts cause refractive changes in the lens leading to frequent changes in spectacles, often every 6 months.

 

b) Blurred vision: Vision becomes progressively cloudy, reducing clarity.

 

c) Sensitivity to light: Light sources, like car headlights may appear glaring or uncomfortable.

 

d) Difficulty seeing at night: Night vision becomes compromised, making driving and other activities challenging.

 

e) Fading colours: Colours lose their vibrancy and appear duller than usual.

 

f) Double vision: Objects may seem to have ghost images or duplicate outlines.

 

 

Prevention and lifestyle tips:

Cataract development is a product both of genetics and natural aging. Hence there is little that can be done to prevent it in most cases. Advances in intraocular lens technology mean that people with even very mild cataracts can expect to experience a significant improvement in vision. Hence developing a cataract is not something to be afraid of. Some metabolic conditions however can accelerate cataract, such as poorly controlled diabetes, low thyroid levels and diseases which require regular prescriptions of cortisol-based steroids, such as prednisolone.

 

The marvels of cataract surgery:

 Fortunately, cataracts are treatable, and modern cataract surgery has evolved into a safe and effective procedure. During the surgery, the clouded lens is replaced with an artificial intraocular lens (IOL). The operation is typically quick, and recovery times have significantly shortened in recent years. Patients often experience improved vision, reduced dependency on glasses, and a renewed zest for life as the world becomes clear again. The newest lenses can correct astigmatism (toric lenses), extend the range of spectacle-free vision (extended depth of focus lenses) and even remove spectacle requirements at all distances in good light (trifocal intraocular lenses). All these lens options will be explained depending on individual circumstances at the pre-operative cataract assessment.

 

Professor Robert MacLaren is one of the world’s leading ophthalmologists with over 20 years of experience in his field. You can book an appointment with Prof MacLaren today on his Top Doctors profile.

By Professor Robert MacLaren
Ophthalmology

Professor Robert MacLaren is a consultant ophthalmologist at Nuffield Health Oxford, The Manor Hospital, as well as at the renowned Oxford Eye Hospital. He also holds the position of Professor of Ophthalmology at the University of Oxford in the UK. He specialises in cataract surgery, retinal surgery, retinal diseases and genetic eye disorders.

In relation to his roles in the NHS, he trains ophthalmologists in retinal surgery and cataract surgery. His previous research has optimised biometric calculations for cataract surgery in extremely long and short eyes. He is experienced in the implantation of all varieties of intraocular lenses used in cataract surgery.  These include toric lenses, extended depth of focus lenses, multifocal lenses and in rare cases black diaphragm lenses. Internationally he trains surgeons in retinal gene therapy surgery and he has led many operations in the USA and across Europe.
 
In addition to his roles at Oxford, he holds the position of Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology and served as an honorary consultant vitreoretinal surgeon at Moorfields Eye Hospital. With a reputation for excellence and dedication to advancing the field of ophthalmology, he has been recognised as an NIHR Senior Investigator and NHS Gold Clinical Excellence Award. Professor MacLaren's contributions to the medical community are commendable, and his numerous fellowships are a testament to his expertise and commitment to the profession.
 
Professor MacLaren is a Fellow of the Royal College of Ophthalmologists, a Fellow of the Royal College of Surgeons and he is one of only a handful of UK ophthalmologists also to be a Fellow of the American College of Surgeons.Furthermore, he served as the former King James IV Professor of Surgery at the Royal College of Surgeons of Edinburgh. His academic achievements have been recognised through his election as a Fellow of the Academy of Medical Sciences, as well as being appointed as a Bodley Fellow of Merton College Oxford.

He is one of the first surgeons in the world to have made a successful retinal implant for visual prosthesis, sometimes described as creating: a 'bionic eye'. In 2016 he performed the world’s first eye operation using a remotely controlled robot. Key events of his work include world's first choroideremia gene therapy trial (2011), electronic retinal implant trials (2012/2015), robot-assisted eye surgery trial (2016), X-linked retinitis pigmentosa gene therapy trial (2017) and the world’s first gene therapy treatment for targeting the mechanism of age related macular degeneration (2019).
 
In the realm of clinical excellence, Professor MacLaren has been recognised with various prestigious awards. Notably, he has received the ARVO Camras Award for translational research, the RP Fighting Blindness Scientist of the Year award, the American Academy of Ophthalmology Achievement Award, the Royal College of Ophthalmologists Keeler Medal, and the Macular Society Clinical Service of the Year award. Such accolades underscore his commitment to advancing patient care and his exceptional contributions to the field of ophthalmology.
 
 

View Profile

Overall assessment of their patients


  • Related procedures
  • Microdermoabrasion
    Microneedling
    Dark circles
    Mesotherapy
    Facelift
    Neck lift
    Botulinum toxin (Botox™)
    Dermal fillers
    Peeling
    Facial paralysis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.